Susan Ruel on Muck Rack

Susan Ruel

Verified
(She/Her)
New York
As seen in: MDedge Hematology and Oncology, Medscape, Soundcloud, Reason, OpenEdition, MDEdge, Minority Nurse, The Boston Musical Intelligencer, News Decoder, Univadis ES
Covers:  health care, global politics (especially Chinese), media history, homelessness, music, and travel
Doesn't Cover: Unlimited (former wire service reporter/editor)

Get in touch with Susan

Contact Susan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Susan Ruel’s Biography

Read Full Bio →

Susan Ruel served until 2026 as a hematology/oncology editor for a global medical news website (Medscape/WebMD). She has worked as an editor on the international desks of the Associated Press and United Press International and has reported from Shanghai, San Francisco, Washington, and New York. She has researched, written, and edited articles and books for the United Nations, including pieces on the Middle East, landmine proliferation, desertification, iodine deficiency syndrome, and oral rehyd…

Susan Ruel’s Journalist Portfolio

See all →
What it took to cover an unpopular war

What it took to cover an unpopular war

In 1962 reporters arriving in Vietnam found an increasing U.S. military presence that wasn't supposed to exis…

View article →
Lung Cancer Expert at ASCO: From Fatal to `Chronic Disease'

Lung Cancer Expert at ASCO: From Fatal to `Chronic Disease'

At ASCO 2024 (largest global oncology meeting), this piece grew out of an interview with Chinese lung cancer…

View article →
Malcolm X Burns Down the Met

Malcolm X Burns Down the Met

review of the Metropolitan Opera's premiere of the X: The Life and Times of Malcolm X, in November 2023

View article →
Decoder: The world wages war on cancer

Decoder: The world wages war on cancer

Revolutionary new cancer treatments are being tested. But to help people everywhere we will need to also revo…

View article →
Marie Colvin shined a light on war-torn corners of the world

Marie Colvin shined a light on war-torn corners of the world

Marie Colvin started as a journalist writing for a New York trade union. She ended up a war correspondent who…

View article →
9/11 scarred Americans. But will we remember its lessons?

9/11 scarred Americans. But will we remember its lessons?

New Yorkers will never forget the attack on our city of 20 years ago. But will Americans remember the lessons…

View article →

Articles

¿Es hora de actualizar los criterios de respuesta de la enfermedad de injerto contra huésped?

|
By Susan Ruel Verified
| Univadis ES Verified
Editado por la Dra. Susan Ruel CONCLUSIÓN PRÁCTICA Con los criterios de respuesta refinada para la enfermedad de injerto contra huésped aguda se observó un mejor rendimiento predictivo que con los criterios convencionales, con valores de área bajo la curva (ABC) y valores predictivos negativos más altos en múltiples cohortes de validación.
Open in Who Shared Issue with article?

Mieloma: un nuevo inyector corporal rivaliza con isatuximab intravenoso y aumenta la comodidad del paciente

|
By Susan Ruel Verified
| Univadis ES Verified
Editado por la Dra. Susan Ruel CONCLUSIÓN PRÁCTICA Un nuevo inyector corporal de un solo uso para isatuximab en el mieloma múltiple no es inferior a la formulación intravenosa estándar en cuanto a eficacia y farmacocinética, y no se han observado alertas de seguridad inesperadas.
Open in Who Shared Issue with article?

Myeloma: OBI Rivals IV Isatuximab, Ups Patient Comfort

|
By Susan Ruel Verified
| Medscape Verified
TOPLINE: A novel, single-use on-body injector (OBI) for isatuximab in multiple myeloma is noninferior to the standard intravenous (IV) formulation in efficacy and pharmacokinetics and has no unexpected safety signals. METHODOLOGY: IRAKLIA is an ongoing study of administration methods of isatuximab as part of a triplet regimen that includes pomalidomide and dexamethasone, commonly used to treat people with relapsed or refractory multiple myeloma.
Open in Who Shared View Duplicates (2) Issue with article?
See all 24 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified